Format
Sort by

Send to

Choose Destination

Search results

Items: 9

1.

Occupational exposures and risk of stomach cancer by histological type.

Santibañez M, Alguacil J, de la Hera MG, Navarrete-Muñoz EM, Llorca J, Aragonés N, Kauppinen T, Vioque J; PANESOES Study Group.

Occup Environ Med. 2012 Apr;69(4):268-75. doi: 10.1136/oemed-2011-100071. Epub 2011 Nov 7.

PMID:
22068174
2.

Esophageal cancer risk by type of alcohol drinking and smoking: a case-control study in Spain.

Vioque J, Barber X, Bolumar F, Porta M, Santibáñez M, de la Hera MG, Moreno-Osset E; PANESOES Study Group.

BMC Cancer. 2008 Aug 1;8:221. doi: 10.1186/1471-2407-8-221.

3.

Occupational exposures and risk of oesophageal cancer by histological type: a case-control study in eastern Spain.

Santibañez M, Vioque J, Alguacil J, Barber X, García de la Hera M, Kauppinen T; PANESOES Study Group.

Occup Environ Med. 2008 Nov;65(11):774-81. doi: 10.1136/oem.2007.037929. Epub 2008 Jul 8.

PMID:
18614460
4.

Cisplatin plus gemcitabine versus a cisplatin-based triplet versus nonplatinum sequential doublets in advanced non-small-cell lung cancer: a Spanish Lung Cancer Group phase III randomized trial.

Alberola V, Camps C, Provencio M, Isla D, Rosell R, Vadell C, Bover I, Ruiz-Casado A, Azagra P, Jiménez U, González-Larriba JL, Diz P, Cardenal F, Artal A, Carrato A, Morales S, Sanchez JJ, de las Peñas R, Felip E, López-Vivanco G; Spanish Lung Cancer Group.

J Clin Oncol. 2003 Sep 1;21(17):3207-13.

PMID:
12947054
5.

Genomic loss of 18p predicts an adverse clinical outcome in patients with high-risk breast cancer.

Climent J, Martinez-Climent JA, Blesa D, Garcia-Barchino MJ, Saez R, Sánchez-Izquierdo D, Azagra P, Lluch A, Garcia-Conde J.

Clin Cancer Res. 2002 Dec;8(12):3863-9.

6.

Phase II trial of paclitaxel plus gemcitabine in patients with locally advanced or metastatic non-small-cell lung cancer.

Isla D, Rosell R, Sánchez JJ, Carrato A, Felip E, Camps C, Artal A, González-Larriba JL, Azagra P, Alberola V, Martin C, Massutí B; Spanish Lung Cancer Group.

J Clin Oncol. 2001 Feb 15;19(4):1071-7.

PMID:
11181671
7.

Prognostic factors in patients with isolated recurrences of breast cancer (stage IV-NED).

Juan O, Lluch A, de Paz L, Prósper F, Azagra P, Marugán I, Martínez-Agulló A, Garcia-Conde J.

Breast Cancer Res Treat. 1999 Jan;53(2):105-12.

PMID:
10326787
8.

Phase II trial of cisplatin and etoposide as first-line therapy in metastatic breast carcinoma.

Lluch A, Azagra P, Cervantes A, Muñoz M, Alberola V, Santabarbara P, García-Conde J.

Oncology. 1994 Jul-Aug;51(4):352-5.

PMID:
8208520
9.

Clinical activity of chronic oral etoposide in previously treated metastatic breast cancer.

Martín M, Lluch A, Casado A, Santabárbara P, Adrover E, Valverde JJ, López-Martín JA, Rodriguez-Lescure A, Azagra P, García-Conde J, et al.

J Clin Oncol. 1994 May;12(5):986-91.

PMID:
8164052
Items per page

Supplemental Content

Loading ...
Write to the Help Desk